Role of fatty acids in the pathogenesis of insulin resistance and NIDDM

Diabetes

Volumn 46, Issue 1, 1997, Pages 3-10

  Boden, Guenther ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0031014830     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.1.3     Document Type: Review

References (74)

1. Harris MI: Impaired glucose tolerance in the US population. Diabetes Care 12:464-474, 1989
2. Assmann G, Schulte H: The prospective cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and relationship to coronary heart disease. Am Heart J 116:1713-1724, 1988
3. McGarry JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-774, 1992
4. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C: Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217-1225, 1988
5. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
6. Sims EAH, Danforth E Jr, Horton ES, Bray GA, Glennon JA, Salans LB: Endocrine and metabolic effects of experimental obesity in man. Rec Prog Horm Res 29:457-496, 1973
7. Goto Y, Nakayama Y, Yagi T: Influence of the World War II food shortage on the incidence of diabetes mellitus in Japan. Diabetes 7:133-135, 1958
8. Schliack V: Mangelernahrung und Diabetes Morbiditat. Z Klin Med 151:382-396, 1954
9. Pascoe WS, Storlien LH: Inducement by fat feeding of basal hyperglycemia in rats with abnormal β-cell function: model for study of etiology and pathogenesis of NIDDM. Diabetes 39:226-233, 1990
10. Gorden ES: Non-esterified fatty acids in blood of obese and lean subjects. Am J Clin Nutr 8:740-747, 1960
11. Reaven GM, Hollenbeck C, Jeng C-Y, Wu MS, Chen Y-D: Measurement of plasma glucose, free fatty acid, lactate and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024, 1988
12. Bjorntorp P, Bergman H, Varnauskas E: Plasma free fatty acid turnover in obesity. Acta Med Scand 185:351-356, 1969
13. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM: Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83:1168-1173, 1989
14. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-789, 1963
15. Schonfeld G, Kipnis DM: Effects of fatty acids on carbohydrate and fatty acid metabolism of rat diaphragm. Am J Physiol 215:513-522, 1968
16. Cassens RG, Bocek RM, Beatty CH: Effect of octanoate on carbohydrate metabolism in red and white muscle of the rhesus monkey. Am J Physiol 217:715-719, 1969
17. Beatty CH, Bocek RM: Interrelation of carbohydrate and palmitate metabolism in skeletal muscle. Am J Physiol 220:1928-1934, 1971
18. Goodman MN, Berger NM, Ruderman NB: Glucose metabolism in rat skeletal muscle at rest: effect of starvation, diabetes, ketone bodies, and free fatty acids. Diabetes 23:881-888, 1974
19. Thiebaud D, DeFronzo RA, Jacot E, Golay A, Acheson K, Maeder E, Jequier E, Felber J-P: Effect of long chain triglyceride infusion on glucose metabolism in man. Metab Clin Exp 31:1128-1136, 1982
20. Felley CP, Felley EM, van Melle GD, Frascarolo P, Jequier E, Felber JP: Impairment of glucose disposal by infusion of triglycerides in humans: role of glycemia. Am J Physiol 256:E747-E752, 1989
21. Bevilacqua S, Bonadonna R, Buzzigoli G, Boni C, Ciociaro D, Maccari F, Giorico MA, Ferrannini E: Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metab Clin Exp 36:502-506, 1987
22. Wolfe B, Klein MS, Peters EJ, Schmidt BF, Wolfe RR: Effect of elevated free fatty acids on glucose oxidation in normal humans. Metab Clin Exp 37:323-329, 1988
23. Bonadonna RC, Zych K, Boni C, Ferrannini E, DeFronzo RA: Time dependence of the interaction between lipid and glucose in humans. Am J Physiol 257:E49-E56, 1989
24. Bevilacqua S, Buzzigoli G, Bonadonna R, Brandi S, Oleggini M, Boni C, Geloni M, Ferrannini E: Operation of Randle's cycle in patients with NIDDM. Diabetes 39:383-389, 1990
25. Lee HU, Lee HK, Koh CS, Min HK: Artificial induction of intravascular lipolysis by lipid-heparin infusions leads to insulin resistance in man. Diabetologia 31:285-290, 1988
26. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, Smith C: Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88:960-966, 1991
27. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
28. Boden G, Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96:1261-1268, 1995
29. Yki-Jarvinen H, Puhakainen HI, Saloranta C, Groop L, Taskinen M-R: Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol 260:E680-E689, 1991
30. Saloranta C, Franssila-Kallunki A, Ekstrand A, Taskinen M-R, Groop L: Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:409-415, 1991
31. Maggs DG, Jacob R, Rife F, Lange R, Leone P, During MJ, Tamborlane WV, Sherwin RS: Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue: evidence for significant lipolysis in skeletal muscle. J Clin Invest 96:370-377, 1995
32. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH: Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest 78:1648-1657, 1986
33. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U: Impact of obesity on metabolism in men and women. J Clin Invest 72:1150-1162, 1983
34. Kolaczynski JW, Boden G: Effects of oleate and fatty acids from omental adipocytes on insulin uptake in rat liver cells. Endocrinology 133:2871-2874, 1993
35. Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 44:863-870, 1995
36. Felber JP, Vanotti A: Effects of fat infusions on glucose tolerance and insulin plasma levels. Med Exp 10:153-156, 1964
37. Pelkonen R, Miettinen A, Taskinen M-R, Nikkila EA: Effect of acute elevation of plasma glycerol, triglyceride and FFA levels on glucose utilization and plasma insulin. Diabetes 17:76-82, 1968
38. Malaisse WJ, Malaisse-Lagae F: Stimulation of insulin secretion by noncarbohydrate metabolites. J Lab Clin Med 72:438-448, 1968
39. Crespin SR, Greenough WB, Steinberg D: Stimulation of insulin secretion by long-chain free fatty acids. J Clin Invest 52:1979-1984, 1973
40. Goberna RJ, Tamarit J Jr, Fussganger R, Tamarit J, Pfeiffer EF: Action of β-hydroxybutyrate, acetoacetate and palmitate on the insulin release from the perfused isolated rat pancreas. Horm Metab Res 6:256-260, 1974
41. Sako Y, Grill VE: A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and βcell oxidation through a process likely coupled to fatty acid oxidation. Endocrinol 127:1580-1589, 1990
42. Zhou Y-P, Grill VE: Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876, 1994
43. Boden G, Chen X, Rosner J, Barton M: Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239-1242, 1995
44. Liang Y, Matschinsky F: Mechanism of action of nonglucose insulin secretagogues. Ann Rev Nutr 14:59-81, 1994
45. Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH: Defective fatty acid mediated β-cell compensation in Zucker diabetic fatty rats. J Biol Chem 271:5633-5637, 1996
46. Williamsson JR, Kreisberg RA, Felts PW: Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 6:247-254, 1966
47. Gonzalez-Manchon C, Ayuso MS, Parrilla R: Control of hepatic gluconeogenesis: role of fatty acid oxidation. Arch Biochem Biophys 271:1-9, 1989
48. Morand C, Remesy C, Demigne C: Fatty acids are potent modulators of lactate utilization in isolated hepatocytes from fed rats. Am J Physiol 264:E816-E823, 1993
49. Jomain-Baum M, Hanson RW: Regulation of hepatic gluconeogenesis in the guinea pig by fatty acids and ammonia. J Biol Chem 250:8978-8985, 1975
50. Williamson J, Browning E, Scholz R: Control mechanisms of gluconeogenesis and ketogenesis. J Biol Chem 224:4607-4616, 1969
51. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
52. Fulcher GR, Walker M, Catalano C, Aquis L, Alberti KGMM: Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 41:1400-1408, 1992
53. Worm D, Henriksen JE, Vaag A, Thye-Ronn P, Melander A, Beck-Nielsen H: Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. J Clin Endocrinol Metab 78:717-721, 1994
54. Vaag A, Skott P, Damsbo P, Gall M-A, Richter EA, Beck-Nielsen H: Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 88:1282-1290, 1991
55. Saloranta C, Koivisto V, Widen E, Falholt K, DeFronzo R, Harkonen M, Groop L: Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol 264:E599-E605, 1993
56. Puhakainen I, Yki-Jarvinen H: Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 42:1694-1699, 1993
57. Ferrannini E, Barrett E, Bevilacqua S, DeFronzo R: Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747, 1983
58. Fanelli C, Calderone S, Epifano L, DeVincenzo A, Modarelli F, Pampanelli S, Perriello G, DeFeo P, Brunetti P, Gerich JE, Bolli GB: Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 92:1617-1622, 1993
59. Boden G, Jadali F: Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 40:686-692, 1991
60. Kelley DE, Mokan M, Simoneau J-A, Mandarino LJ: Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92:91-98, 1993
61. Rossetti L, Lee YT, Ruiz J, Aldridge SC, Shamoon H, Boden G: Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol 265:E761-E769, 1993
62. Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating glucose-induced desensitization of glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712, 1991
63. Traxinger RR, Marshall S: Recovery of maximal insulin responsiveness and insulin sensitivity after induction of insulin resistance in primary cultured adipocytes. J Biol Chem 264:8156-8163, 1989
64. Robinson KA, Sens DA, Buse MG: Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles: study of mechanisms in muscle and in rat-1 fibroblasts overexpressing the human insulin receptor. Diabetes 42:1333-1346, 1993
65. 2. J Biol Chem 271:1138-1144, 1996
66. Ginsberg BH, Brown TJ, Simon I, Spector AA: Effect of membrane lipid environment on the properties of insulin receptors. Diabetes 30:773-780, 1981
67. Grunfeld C, Baird KL, Kahn CR: Maintenance of 3T3-L1 cells in cultured media containing saturated fatty acids decreases insulin binding and insulin action. Biochem Biophys Res Commun 103:219-226, 1981
68. Farias RN: Insulin-membrane interactions and membrane fluidity changes. Biochem Biophys Acta 906:459-468, 1987
69. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV: The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328:238-244, 1993
70. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
71. Hurel S, Ofei F, Wells AN, Newkirk J, Sopwith M, Turnbull D, Taylor R: TNF-α and insulin sensitivity in humans: effects in vivo of antibody blockade in obese NIDDM patients and in vitro upon human cultured myotubes. Exp Clin Endocrinol Diabetes 104 (Suppl. 2):59-60, 1996
72. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM: Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α. J Clin Invest 94:1543-1549, 1994
73. Van Der Poll T, Romijn JA, Endert E, Borm JJJ, Buller HR, Sauerwein HP: Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 24:E457-E465, 1991
74. Boden G, Ruiz J, Kim C-J, Chen X: Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects. Am J Physiol 270:E251-E258, 1996